{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:51:42Z","timestamp":1781106702933,"version":"3.54.1"},"reference-count":84,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAPES","award":["88887.877789\/2023-00"],"award-info":[{"award-number":["88887.877789\/2023-00"]}]},{"name":"CAPES","award":["88887.798411\/2022-00"],"award-info":[{"award-number":["88887.798411\/2022-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Recent studies have shown the promising potential of probiotics, especially the bacterial genus Bifidobacterium, in the treatment of liver diseases. In this work, a systematic review was conducted, with a focus on studies that employed advanced Next Generation Sequencing (NGS) technologies to explore the potential of Bifidobacterium as a probiotic for treating liver pathologies such as Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Alcoholic Liver Disease (ALD), Cirrhosis, and Hepatocelullar Carcinoma (HCC) and its impact on the microbiota. Our results indicate that Bifidobacterium is a safe and effective probiotic for treating liver lesions. It successfully restored balance to the intestinal microbiota and improved biochemical and clinical parameters in NAFLD, ALD, and Cirrhosis. No significant adverse effects were identified. While more research is needed to establish its efficacy in treating NASH and HCC, the evidence suggests that Bifidobacterium is a promising probiotic for managing liver lesions.<\/jats:p>","DOI":"10.3390\/life14020239","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T03:53:46Z","timestamp":1707450826000},"page":"239","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota"],"prefix":"10.3390","volume":"14","author":[{"given":"Gabriel Henrique","family":"Hizo","sequence":"first","affiliation":[{"name":"Graduate Program in Gastroenterology and Hepatology Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-003, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-9697","authenticated-orcid":false,"given":"Pabulo Henrique","family":"Rampelotto","sequence":"additional","affiliation":[{"name":"Bioinformatics and Biostatistics Core Facility, Instituto de Ci\u00eancias B\u00e1sicas da Sa\u00fade, Universidade Federal do Rio Grande do Sul, Porto Alegre 91501-907, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcmgh.2015.04.003","article-title":"The Gut Microbiota and Liver Disease","volume":"1","author":"Llorente","year":"2015","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Pezzino, S., Sofia, M., Faletra, G., Mazzone, C., Litrico, G., La Greca, G., and Latteri, S. (2022). Gut-Liver Axis and Non-Alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology, 11.","DOI":"10.3390\/biology11111622"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The Gut-Liver Axis in Liver Disease: Pathophysiological Basis for Therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The Gut\u2013Liver Axis and Gut Microbiota in Health and Liver Disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Song, Q., and Zhang, X. (2022). The Role of Gut\u2013Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030524"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Pezzino, S., Sofia, M., Mazzone, C., Castorina, S., Puleo, S., Barchitta, M., Agodi, A., Gallo, L., La Greca, G., and Latteri, S. (2023). Gut Microbiome in the Progression of NAFLD, NASH and Cirrhosis, and its Connection with Biotics: A Bibliometric Study Using Dimensions Scientific Research Database. Biology, 12.","DOI":"10.3390\/biology12050662"},{"key":"ref_7","first-page":"5","article-title":"The Mechanism of Dysbiosis in Alcoholic Liver Disease Leading to Liver Cancer","volume":"6","author":"Abenavoli","year":"2020","journal-title":"Hepatoma Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in Health and Diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yoon, S.J., Yu, J.S., Min, B.H., Gupta, H., Won, S.M., Park, H.J., Han, S.H., Kim, B.Y., Kim, K.H., and Kim, B.K. (2023). Bifidobacterium-Derived Short-Chain Fatty Acids and Indole Compounds Attenuate Nonalcoholic Fatty Liver Disease by Modulating Gut-Liver Axis. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1129904"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","article-title":"The Role of the Gut Microbiome in Chronic Liver Disease: The Clinical Evidence Revised","volume":"1","author":"Schwenger","year":"2019","journal-title":"JHEP Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jmf.2018.4357","article-title":"Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury","volume":"23","author":"Gu","year":"2020","journal-title":"J. Med. Food."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Dyshlyuk, L.S., Milentyeva, I.S., Asyakina, L.K., Ostroumov, L.A., Osintsev, A.M., and Pozdnyakova, A.V. (2022). Using Bifidobacterium and Propionibacterium Strains in Probiotic Consortia to Normalize the Gastrointestinal Tract. Braz. J. Biol., 84.","DOI":"10.1590\/1519-6984.256945"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kim, J.Y., Bang, S.J., Kim, J.Y., Choi, E.J., Heo, K., Shim, J.J., and Lee, J.L. (2022). The Probiotic Strain Bifidobacterium animalis ssp. lactis HY8002 Potentially Improves the Mucosal Integrity of an Altered Intestinal Microbial Environment. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.817591"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1038\/s41598-021-82726-y","article-title":"Comparison between 16S rRNA and Shotgun Sequencing Data for the Taxonomic Characterization of the Gut Microbiota","volume":"11","author":"Durazzi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A Web and Mobile App for Systematic Reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hooijmans, C.R., Rovers, M.M., De Vries, R.B.M., Leenaars, M., Ritskes-Hoitinga, M., and Langendam, M.W. (2014). SYRCLE\u2019s Risk of Bias Tool for Animal Studies. BMC Med. Res. Methodol., 14.","DOI":"10.1186\/1471-2288-14-43"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"822429","DOI":"10.3389\/fnut.2022.822429","article-title":"Intestinal Microbiota Contributes to the Improvement of Alcoholic Hepatitis in Mice Treated with Schisandra Chinensis Extract","volume":"9","author":"Xiang","year":"2022","journal-title":"Front. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.3168\/jds.2021-21265","article-title":"Intake of Bifidobacterium lactis Probio-M8 Fermented Milk Protects against Alcoholic Liver Disease","volume":"105","author":"He","year":"2022","journal-title":"J. Dairy Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"104045","DOI":"10.1016\/j.jff.2020.104045","article-title":"Bifidobacterium breve ATCC15700 Pretreatment Prevents Alcoholic Liver Disease through Modulating Gut Microbiota in Mice Exposed to Chronic Alcohol Intake","volume":"72","author":"Tian","year":"2020","journal-title":"J. Funct. Foods"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s00394-018-1709-y","article-title":"Improved Hemodynamic and Liver Function in Portal Hypertensive Cirrhotic Rats after Administration of B. pseudocatenulatum CECT 7765","volume":"58","author":"Zapater","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Lu, H., Zhu, X., Wu, L., Lou, X., Pan, X., Liu, B., Zhang, H., Zhu, L., Li, L., and Wu, Z. (2023). Alterations in the Intestinal Microbiome and Metabolic Profile of Patients with Cirrhosis Supplemented with Lactulose, Clostridium butyricum, and Bifidobacterium longum infantis: A Randomized Placebo-Controlled Trial. Front. Microbiol., 14.","DOI":"10.3389\/fmicb.2023.1169811"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1039\/C9FO02905B","article-title":"Bifidobacterium adolescentis and Lactobacillus rhamnosus Alleviate Non-Alcoholic Fatty Liver Disease Induced by a High-Fat, High-Cholesterol Diet through Modulation of Different Gut Microbiota-Dependent Pathways","volume":"11","author":"Wang","year":"2020","journal-title":"Food Funct."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Wang, L., Jiao, T., Yu, Q., Wang, J., Wang, L., Wang, G., Zhang, H., Zhao, J., and Chen, W. (2022). Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010084"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lv, H., Tao, F., Peng, L., Chen, S., Ren, Z., Chen, J., Yu, B., Wei, H., and Wan, C. (2023). Vitro Probiotic Properties of Bifidobacterium animalis Subsp. lactis SF and its Alleviating Effect on Non-Alcoholic Fatty Liver Disease. Nutrients, 15.","DOI":"10.3390\/nu15061355"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00535-022-01909-0","article-title":"Pathogenic Effects of Desulfovibrio in the Gut on Fatty Liver in Diet-Induced Obese Mice and Children with Obesity","volume":"57","author":"Lin","year":"2022","journal-title":"J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1038\/s41598-019-42059-3","article-title":"Randomized, Double-Blind, Placebo-Controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease","volume":"9","author":"Ahn","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ayob, N., Muhammad Nawawi, K.N., Mohamad Nor, M.H., Raja Ali, R.A., Ahmad, H.F., Oon, S.F., and Mohd Mokhtar, N. (2023). The Effects of Probiotics on Small Intestinal Microbiota Composition, Inflammatory Cytokines, and Intestinal Permeability in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11020640"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1053\/j.gastro.2020.01.031","article-title":"Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients with Nonalcoholic Fatty Liver Disease","volume":"158","author":"Scorletti","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3920\/BM2014.0103","article-title":"The History of Probiotics: The Untold Story","volume":"6","author":"Ozen","year":"2015","journal-title":"Benef. Microbes"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/14740338.2014.872627","article-title":"A Systematic Review of the Safety of Probiotics","volume":"13","author":"Didari","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s13197-015-2011-0","article-title":"Probiotics\u2014The Versatile Functional Food Ingredients","volume":"53","author":"Syngai","year":"2016","journal-title":"J. Food Sci. Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"100403","DOI":"10.1016\/j.xcrm.2021.100403","article-title":"Fecal Microbiota Transplantation and Fiber Supplementation, Better Together?","volume":"2","author":"Hanssen","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Chen, J., Chen, X., and Ho, C.L. (2021). Recent Development of Probiotic Bifidobacteria for Treating Human Diseases. Front. Bioeng. Biotechnol., 9.","DOI":"10.3389\/fbioe.2021.770248"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Hidalgo-Cantabrana, C., Delgado, S., Ruiz, L., Ruas-Madiedo, P., S\u00e1nchez, B., and Margolles, A. (2017). Bifidobacteria and Their Health-Promoting Effects. Microbiol. Spectr., 5.","DOI":"10.1128\/microbiolspec.BAD-0010-2016"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1751-7915.13460","article-title":"Protective Effects of Bifidobacteria against Enteropathogens","volume":"12","author":"Aw","year":"2019","journal-title":"Microb. Biotechnol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kim, H., Jeong, Y., Kang, S., You, H.J., and Ji, G.E. (2020). Co-Culture with Bifidobacterium catenulatum Improves the Growth, Gut Colonization, and Butyrate Production of Faecalibacterium prausnitzii: In Vitro and In Vivo Studies. Microorganisms, 8.","DOI":"10.3390\/microorganisms8050788"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.7150\/ijms.18354","article-title":"Bifidobacterium pseudocatenulatum CECT 7765 Supplementation Restores Altered Vascular Function in an Experimental Model of Obese Mice","volume":"14","author":"Mauricio","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1615\/ForumImmunDisTher.2016017095","article-title":"Activation of Natural Killer Cells by Probiotics","volume":"7","author":"Aziz","year":"2016","journal-title":"Forum Immunopathol. Dis. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13048-020-00668-x","article-title":"Anti-Tumor Activities of Probiotics in Cervical Cancer","volume":"13","author":"Jahanshahi","year":"2020","journal-title":"J. Ovarian Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1349-7006.2006.00221.x","article-title":"Genetically Engineered Bifidobacterium longum for Tumor-Targeting Enzyme-Prodrug Therapy of Autochthonous Mammary Tumors in Rats","volume":"97","author":"Sasaki","year":"2006","journal-title":"Cancer Sci."},{"key":"ref_43","first-page":"835","article-title":"Anti-Colon Cancer Activity of Bifidobacterium Metabolites on Colon Cancer Cell Line SW742. Turk","volume":"30","author":"Bahmani","year":"2019","journal-title":"J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Arra\u00f1o, V., and Mart\u00edn-Pel\u00e1ez, S. (2021). Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review. Nutrients, 13.","DOI":"10.3390\/nu13103627"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3920\/BM2014.0014","article-title":"Potential Probiotic Bifidobacterium animalis ssp. lactis 420 Prevents Weight Gain and Glucose Intolerance in Diet-Induced Obese Mice","volume":"5","author":"Stenman","year":"2014","journal-title":"Benef. Microbes."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Sung, H.K., Youn, S.J., Choi, Y., Eun, S.W., and Shin, S.M. (2023). Body Fat Reduction Effect of Bifidobacterium breve B-3: A Randomized, Double-Blind, Placebo Comparative Clinical Trial. Nutrients, 15.","DOI":"10.3390\/nu15010028"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Kim, M.J., Ku, S., Kim, S.Y., Lee, H.H., Jin, H., Kang, S., Li, R., Johnston, T.V., Park, M.S., and Ji, G.E. (2018). Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19051422"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13073-021-00942-7","article-title":"Effectiveness and Safety of Bifidobacterium and Berberine in Human Hyperglycemia and Their Regulatory Effect on the Gut Microbiota: A Multi-Center, Double-Blind, Randomized, Parallel-Controlled Study","volume":"13","author":"Ming","year":"2021","journal-title":"Genome Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Lu, H., Zhao, W., Liu, W.H., Sun, T., Lou, H., Wei, T., Hung, W.L., and Chen, Q. (2021). Safety Evaluation of Bifidobacterium lactis BL-99 and Lacticaseibacillus paracasei K56 and ET-22 in vitro and in vivo. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.686541"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"812882","DOI":"10.3389\/fphys.2021.812882","article-title":"Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice","volume":"12","author":"Warner","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"goac074","DOI":"10.1093\/gastro\/goac074","article-title":"Clinical Outcomes and Gut Microbiota Analysis of Severe Alcohol-Associated Hepatitis Patients Undergoing Healthy Donor Fecal Transplant or Pentoxifylline Therapy: Single-Center Experience from Kerala","volume":"10","author":"Philips","year":"2022","journal-title":"Gastroenterol. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Magne, F., Gotteland, M., Gauthier, L., Zazueta, A., Pesoa, S., Navarrete, P., and Balamurugan, R. (2020). The Firmicutes\/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients, 12.","DOI":"10.3390\/nu12051474"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A Multisociety Delphi Consensus Statement on New Fatty Liver Disease Nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"558525","DOI":"10.3389\/fphar.2020.558525","article-title":"Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating Gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-M\u03c8-Nuclear Factor-\u03baB-Nod-Like Receptor Protein 3 Pathway via Gut-Liver Axis in Mice","volume":"11","author":"Bao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"112309","DOI":"10.1016\/j.foodres.2022.112309","article-title":"Inulin Intervention Attenuates Hepatic Steatosis in Rats via Modulating Gut Microbiota and Maintaining Intestinal Barrier Function","volume":"163","author":"Yang","year":"2023","journal-title":"Food Res. Int."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Pan, X., Kaminga, A.C., Liu, A., Wen, S.W., Luo, M., and Luo, J. (2021). Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children with Nonalcoholic Fatty Liver Disease. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.683743"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3748\/wjg.v24.i23.2468","article-title":"Dynamic Alterations in the Gut Microbiota and Metabolome during the Development of Methionine-Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis","volume":"24","author":"Ye","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1097\/TXD.0000000000001033","article-title":"Characterization of Gut Microbiome in Liver Transplant Recipients with Nonalcoholic Steatohepatitis","volume":"6","author":"Satapathy","year":"2020","journal-title":"Transplant. Direct."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00394-018-1721-2","article-title":"Histological Improvement of Non-Alcoholic Steatohepatitis with a Prebiotic: A Pilot Clinical Trial","volume":"58","author":"Bomhof","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10620-011-1887-4","article-title":"Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non-Alcoholic Steatohepatitis","volume":"57","author":"Malaguarnera","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/MEG.0000000000001494","article-title":"Characterization of Blood Microbiota in Patients with Liver Cirrhosis","volume":"31","author":"Kajihara","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Wei, X., Yan, X., Zou, D., Yang, Z., Wang, X., Liu, W., Wang, S., Li, X., Han, J., and Huang, L. (2013). Abnormal Fecal Microbiota Community and Functions in Patients with Hepatitis B Liver Cirrhosis as Revealed by a Metagenomic Approach. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-175"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Dubinkina, V.B., Tyakht, A.V., Odintsova, V.Y., Yarygin, K.S., Kovarsky, B.A., Pavlenko, A.V., Ischenko, D.S., Popenko, A.S., Alexeev, D.G., and Taraskina, A.Y. (2017). Links of Gut Microbiota Composition with Alcohol Dependence Syndrome and Alcoholic Liver Disease. Microbiome, 5.","DOI":"10.1186\/s40168-017-0359-2"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"762930","DOI":"10.3389\/fmed.2021.762930","article-title":"Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients","volume":"8","author":"Lu","year":"2021","journal-title":"Front. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1038\/nature14851","article-title":"Decompensated Cirrhosis and Microbiome Interpretation","volume":"525","author":"Bajaj","year":"2015","journal-title":"Nature"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e00495","DOI":"10.14309\/ctg.0000000000000495","article-title":"Area Deprivation Index and Gut-Brain Axis in Cirrhosis","volume":"13","author":"Bajaj","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Hizo, G.H., and Rampelotto, P.H. (2023). The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies. Microorganisms, 11.","DOI":"10.3390\/microorganisms11122999"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Eom, J.A., Kwon, G.H., Kim, N.Y., Park, E.J., Won, S.M., Jeong, J.J., Raja, G., Gupta, H., Asmelash Gebru, Y., and Sharma, S. (2021). Diet-Regulating Microbiota and Host Immune System in Liver Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126326"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2147\/JHC.S272213","article-title":"NAFLD-Associated HCC: Progress and Opportunities","volume":"8","author":"Geh","year":"2021","journal-title":"J. Hepatocel. Carcinoma"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/hep.15.40","article-title":"Role of Alcohol in the Development and Progression of Hepatocellular Carcinoma","volume":"3","author":"McKillop","year":"2016","journal-title":"Hepatic Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/curroncol30020141","article-title":"Altered Gut Microbiota Composition and its Potential Association in Patients with Advanced Hepatocellular Carcinoma","volume":"30","author":"Huo","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep4.1905","article-title":"Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma","volume":"6","author":"Ponziani","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jhep.2023.07.005","article-title":"Bifidobacterium pseudolongum-Generated Acetate Suppresses Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma","volume":"79","author":"Song","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1128\/JCM.01228-07","article-title":"16S rRNA Gene Sequencing for Bacterial Identification in the Diagnostic Laboratory: Pluses, Perils, and Pitfalls","volume":"45","author":"Janda","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1038\/s41598-023-30764-z","article-title":"Determining the Most Accurate 16S rRNA Hypervariable Region for Taxonomic Identification from Respiratory Samples","volume":"13","author":"Palomeque","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Lin, H., and Peddada, S.D. (2020). Analysis of Microbial Compositions: A Review of Normalization and Differential Abundance Analysis. NPJ Biofilms Microbiomes, 6.","DOI":"10.1038\/s41522-020-00160-w"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41467-022-28034-z","article-title":"Microbiome Differential Abundance Methods Produce Different Results Across 38 Datasets","volume":"13","author":"Nearing","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., and Huttenhower, C. (2011). Metagenomic Biomarker Discovery and Explanation. Genome Biol., 12.","DOI":"10.1186\/gb-2011-12-s1-p47"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Litwinowicz, K., and Gamian, A. (2023). Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032461"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.mimet.2009.09.012","article-title":"Illumina High-Throughput Sequencing","volume":"79","author":"Lazarevic","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1007\/s00253-022-12251-z","article-title":"Comparison of iSeq and MiSeq as the Two Platforms for 16S rRNA Sequencing in the Study of the Gut of Rat Microbiome","volume":"106","author":"Salamon","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","article-title":"Reporting Guidelines for Human Microbiome Research: The STORMS Checklist","volume":"27","author":"Mirzayi","year":"2021","journal-title":"Nat. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/2\/239\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:57:24Z","timestamp":1760104644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/14\/2\/239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":84,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["life14020239"],"URL":"https:\/\/doi.org\/10.3390\/life14020239","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}